-
For patients with poor blood sugar control, proteinuria, and non-alcoholic fatty liver disease, please check if there is a new plan
Time of Update: 2022-08-15
Metabolic syndrome type 2 diabetes (T2DM) diabetic nephropathy A2G1 stage non-alcoholic fatty liver disease high Lipidemia▌ Treatment plan: Stage 1: Pre-hospital treatment regimen After the patient's self-conscious blood sugar control was still poor after metformin 500 mg three times a day (TID), the drug was discontinued voluntarily Stage 2: Post-hospital treatment regimen semaglutide 0.
-
Empowering the construction of specialists to create a healthy China "Breast Cancer Scientific Management Promotion Project" launched
Time of Update: 2022-05-24
<> /* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prne
-
AstraZeneca's new crown antibody cocktail therapy can provide protection for at least 6 months in high-risk groups
Time of Update: 2022-05-17
AstraZeneca said today that its long-acting antibody cocktail, Evusheld (tixagevimab and cilgavimab), compared with placebo in a late-stage pre-exposure prophylaxis trial, reduced patients with symptomatic COVID-19 infection six months later.
-
U.S. crude prices jump to highest since 2013
Time of Update: 2022-04-21
crude oil prices climbed to their highest level since 2013 in overnight trading on Tuesday .
Brent, the global benchmark, topped $110 a barrel as crude prices continued to soar .
Brent crude, the global benchmark, rose 5.
-
Russian Railways opens new route for transporting agricultural products from China to Russia
Time of Update: 2022-04-19
On March 26, the train traveled from Nongzhong Station in Zibo City, Shandong Province, China to Selyadino Station in Moscow Oblast, Russia, passing through Dostyk Station in Kazakhstan, with an estimated travel time of 18 days .
-
Bibate Pharmaceutical's CDK4/6 inhibitors are approved for Phase 3 clinical trials
Time of Update: 2022-01-10
ArticleMedicine GuanlanOn December 22, Bibate Pharmaceutical announced that its phase 3 clinical trial application of the CDK4/6 inhibitor BEBT-209 combined with fulvestrant in the treatment of HR+/HER2- advanced breast cancer has been approved by the China National Medical Products Administration.
-
On the evening of October 26, it was announced that a number of pharmaceutical companies disclosed their three quarterly reports, and one company released an annual performance forecast
Time of Update: 2021-11-15
62%; non-recurring gains and losses attributable to shareholders of listed companies were deducted The net profit of 905 million yuan, a year-on-year increase of 19.
On the same day, the third quarter report disclosed by Liuyao shares showed that the company achieved operating income of 12.
-
Professor Li Yulong was invited to be interviewed by "Neuron" magazine and talked about the development of optical imaging tools and whole brain research
Time of Update: 2021-11-12
In the "Neuron" special issue published on November 3, 2021, Professor Li Yulong personally shared a number of important issues related to the development of optical imaging tools and the study of the whole brain in the form of question-and-answer interviews .
-
Nippon and JD.com releases a solution for the whole house beauty seam and edge, creating an intimate and seamless healthy home space
Time of Update: 2021-11-11
As one of the "Top Ten Most Influential Brands in the Beauty Sewing Industry in 2020", Nippon Paint continues to invest in technology research and development, and promotes innovation and breakthroughs in the industry in terms of product system, service standards, construction training and certification .
-
1 billion cephalosporin injection Haisco overtakes the first review
Time of Update: 2021-11-05
0 Chinese Drug Evaluation DatabaseAccording to data from Mi Nei. com, as of now, Haisco and its subsidiaries have reviewed/deemedly reviewed 19 products (including the approved products this time), of which 10 are injections .
-
Measles virus not only activates the RNA virus pathway, but also activates the DNA virus pathway
Time of Update: 2021-11-03
The team recently discovered that infection by the measles virus (MeV) causes the activation of RNA and DNA viral immune responses .
After measles virus infection, mitochondrial DNA is released into the cell .
-
Chia Tai Tianqing storms innovative drugs this year, 13 Class 1 new drugs approved for clinical trials
Time of Update: 2021-09-18
Source: CDE official website From September until now, CP Tianqing Pharmaceuticals has two Class 1 new drugs declared for clinical use, namely TQB2868 injection and TQB2916 injection.
-
Six more standards in the field of stem cells to further ensure biosafety and ethical norms
Time of Update: 2021-08-08
Peng Yaojin, an associate researcher at the Institute of Stem Cell and Regenerative Medicine Innovation of the Chinese Academy of Sciences, said that the development of biobanks requires special attention to ethical issues such as informed consent and privacy protection .
-
Develop mRNA drugs
Time of Update: 2021-08-08
Transfer from | Pharmaceutical Mission HillsOn July 5, “Near Neighbor Bio,” a cutting-edge in the mRNA field, announced that it had completed more than 10 million yuan in seed + round financing, which was exclusively completed by Yuansheng Ventures .
-
It was accidentally discovered that the brain's synaptic connections keep the password young
Time of Update: 2021-07-28
McCabe said that if the neurons in the brain are a computer network, then induced releases are packets of information exchanged by machines, and minis are pings-short electrical signals that determine whether there is a connection between two computers .
